Delayed cutaneous adverse reaction of the astrazeneca covid-19 vaccine in a breastfed female infant: a coincidence or a rare effect?

HIGHLIGHTS

• who: Patru00edcia Diogo and colleagues from the Institute of Endodontics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal have published the paper: Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?, in the Journal: Vaccines 2022, 10, 602. of /2022/

SUMMARY

The vaccination of lactating women with inactivated or recombinant vaccines has been advised as safe to breastfeeding mothers and their infants. The ChAdOx1 nCoV-19 vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and consists of a replication . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.